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PEffects of Exercise Training on
Myocardial Energy Metabolism and
Ventricular Function Assessed by Quantitative
Phosphorus-31 Magnetic Resonance Spectroscopy and
Magnetic Resonance Imaging in Dilated Cardiomyopathy
Meinrad Beer, MD,* Doris Wagner, MD,† Jonathan Myers, PHD,‡ Jörn Sandstede, MD,*
Herbert Köstler, PHD,* Dietbert Hahn, MD,* Stefan Neubauer, MD, FRCP,§ Paul Dubach, MD†
Würzburg, Germany; Chur, Switzerland; Palo Alto, California; and Oxford, United Kingdom
Objectives The present study investigated changes in cardiac energy metabolism and function in patients with dilated car-
diomyopathy (DCM) before and after exercise training (ET) with phosphorus-31 magnetic resonance spectros-
copy (MRS) in combination with magnetic resonance imaging (MRI).
Background Exercise training might have a beneficial role on myocardial function and oxidative metabolism in DCM, but it is
unclear whether the additional load on the failing heart leads to deterioration of cardiac energy metabolism.
Methods Twenty-four patients were randomized to an exercise (age 53  12 years) or a control (age 56  6 years) group.
Supervised ET was performed for 2 months, followed by 6 months of self-regulated training. At baseline and 2
and 8 months, maximal exercise testing along with quantitative MRS and MRI studies were performed.
Results The effectiveness of ET was demonstrated by a 17% increase in peak oxygen uptake (p  0.05). Exercise train-
ing improved left ventricular (LV) end-systolic volume (p  0.05) and LV ejection fraction (30  15% vs. 37  15%;
p  0.01) but not right ventricular parameters. The improvement in cardiac function was not accompanied by
changes in cardiac high-energy phosphate concentrations; phosphocreatine, adenosine triphosphate, and the
phosphocreatine/adenosine triphosphate ratio were all unchanged after training.
Conclusions The observation that LV function improved and LV energy metabolism remained unchanged suggests that the
beneficial effect of ET on LV function is achieved without adversely affecting metabolism. These findings lend
further support for the use of ET as an adjunct therapy in DCM. (J Am Coll Cardiol 2008;51:1883–91) © 2008
by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.09.075o
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cerangement of cardiac energetics is one of the hallmarks of
he failing myocardium (1) and has been implicated as a
ajor contributor to the pathophysiology of contractile
ysfunction (2). Myocardial high energy phosphate metab-
lism is a sensitive indicator of energetic derangement and
an be measured noninvasively by phosphorus-31 (31P)
agnetic resonance spectroscopy (MRS) (3,4). We and
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erzstiftung and Merck, Switzerland; and the British Heart Foundation, United
ingdom.e
Manuscript received April 23, 2007; revised manuscript received August 27, 2007,
ccepted September 23, 2007.thers have shown that, in the failing human heart, levels of
hosphocreatine (PCr), adenosine triphosphate (ATP), and
heir ratio (PCr/ATP ratio) are all reduced (5,6), and these
ndexes are correlated with left ventricular (LV) dysfunction
nd clinical status (6). In patients with dilated cardiomyop-
thy (DCM), the PCr/ATP ratio has also been shown to be
strong predictor of prognosis (7).
See page 1892
The past 15 years of clinical trials in heart failure have
hown that energy-sparing treatments, such as angiotensin-
onverting enzyme (ACE) inhibitors or beta-blockers (8–11),
mprove prognosis in heart failure, whereas energy-
ostly treatment with catecholamines (12) or phosphodi-
sterase (PDE) inhibitors (13) increases mortality. Inter-
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Myocardial Metabolism and Exercise Training in DCM May 13, 2008:1883–91estingly, it is conceivable that
therapeutic exercise training
(ET) might be an exception to
this rule, at least in patients with
nonischemic heart failure, where
this form of treatment has met
substantial recent enthusiasm
(14). Besides favorable effects on
peripheral adaptations (15), ET
seems to have direct effects on the
heart, including improved myocar-
dial perfusion, volumes, and func-
tion (16,17). Additionally, ET
has recently been associated with
lower mortality and hospital re-
admission in heart failure (18–
20). Recent positron emission to-
mography (PET) studies have
demonstrated marked alterations
in myocardial oxygen metabo-
lism in heart failure (21), and ET
seems to have a favorable influ-
ence on myocardial oxidative
metabolism (22).
Therefore, in the present controlled study, we tested the
ypothesis that chronic ET in patients with moderate
CM improves cardiac function and might benefit cardiac
nergy metabolism. To achieve this, we sequentially studied
edentary patients and those subjected to ET with a mod-
rate reduction of LV ejection fraction (EF) in echocardi-
graphy (mean 27  10), with magnetic resonance imaging
MRI) to measure cardiac volumes and 31P-MRS to quan-
ify absolute and relative levels of cardiac high-energy
hosphates.
ethods
atient characteristics. Twenty-four patients with non-
schemic DCM were randomized to an exercise or a control
roup (12 each). Inclusion criteria were a reduction in
VEF below 40% and absence of coronary artery disease as
onfirmed by invasive coronary angiography. Table 1 sum-
arizes baseline data. Both groups had similar clinical and
emographic data, including age, height, weight, pulmonary
unction, medication status, and peak oxygen uptake (VO2).
ll subjects were receiving maximal therapeutic medical
herapy as determined by their personal physician.
Subjects were evaluated before and after a 2-month
raining period and also after an 8-month follow-up. A
2-year-old male patient from the exercise group died after
months—who refused training after the baseline exami-
ation—and a 72-year-old female patient from the control
roup died after the baseline examination. Two additional
atients in the control group refused to be tested at the
-month evaluation. Therefore, 11 patients in each group
Abbreviations
and Acronyms
ATP  adenosine
triphosphate
DCM  dilated
cardiomyopathy
EF  ejection fraction
ET  exercise training
LV  left ventricular
MRI  magnetic resonance
imaging
MRS  magnetic
resonance spectroscopy
PCr  phosphocreatine
PET  positron emission
tomography
RV  right ventricular
SLOOP  Spatial
Localization with Optimum
Pointspread Function
VO2  oxygen uptake
31P  phosphorus-31ad at least 1 repeated imaging analysis, and the presented cata are based on these patient groups. Patients in the
xercise group underwent 5 supervised training sessions/
eek lasting 45 min, whereas patients in the control group
eceived standard care. No change of drug types and/or
osages occurred in either group during the 8 months of
ollow-up.
Written informed consent was obtained from all patients,
nd the study was approved by the local ethics committee. All
atients had stable symptoms before randomization. All were
imited by fatigue, dyspnea, or both on baseline exercise testing,
nd none had clinical evidence of pulmonary disease. None of
he patients had a pacemaker; a history of metal frag-
ents, implants, or vascular clips; significant arrhythmias;
nstable angina pectoris; or claustrophobia.
xercise testing. All patients were requested to abstain
rom food, coffee, and tobacco products for at least 3 h
efore exercise. Standard pulmonary function tests were
erformed. With an individualized ramp protocol, maximal
xercise testing was performed with an electrically braked
ycle ergometer (16). The patient’s subjective level of
xertion was quantified each minute with the Borg 6–20
cale (16), and all tests were continued to volitional fatigue/
yspnea. With the Schiller CS-200 metabolic system (Baar,
witzerland), respiratory gas exchange variables were ac-
uired continuously throughout exercise. Gas exchange
ariables analyzed included VO2, carbon dioxide production,
inute ventilation, respiratory rate, tidal volume, oxygen
ulse, and respiratory exchange ratio. The lactate threshold
as determined by 2 experienced observers (J.M. and P.D.)
linded to the study group.
T. Subjects in the exercise group participated in training
essions as outpatients for 2 months. Five sessions/week for
duration of 45 min were performed. Warm-up and
aseline Characteristics
Table 1 Baseline Characteristics
Exercise Group Control Group
Demographic data
Age (yrs) 52.8 12 58.2 6
Height (cm) 173 6.3 171 4.8
Weight (kg) 75.6 15 77.8 14
Ejection fraction (%) 29 10 25 10
Maximal oxygen uptake (ml/kg/min) 21.7 3.8 19.5 2.7
Pulmonary function
FEV1 2.85 0.96 2.71 0.67
FEV1 % of normal 84.6 24.5 90.7 16.5
Forced vital capacity 3.77 1.01 3.28 0.80
Forced vital capacity % of normal 90.5 19.8 90.2 16.5
Peak expiratory flow 5.81 1.14 6.31 1.94
Medications
Digoxin 5 6
ACE inhibitor 12 11
Diuretics 10 10
Beta-blockers 9 9
Others 5 4
CE  angiotensin-converting enzyme; FEV1  forced expiratory volume 1 s.ool-down periods preceded and followed each exercise
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May 13, 2008:1883–91 Myocardial Metabolism and Exercise Training in DCMession. Cycle ergometry training was emphasized, but a
ariety of dynamic exercises were included. Exercise inten-
ity was targeted to maintain a level commensurate with
0% to 80% of maximal VO2 and a continuous perceived
xertion rating between 13 and 15 (Borg 6 to 20 scale).
xercise intensity was progressed throughout the study period
n an individualized basis as tolerated. All exercise sessions
ere supervised directly by a medical resident, an exercise
hysiologist, or both. Between the 2- and 8-month evaluation
eriods, subjects in the exercise group were counseled and
ncouraged to remain physically active; we recently demon-
trated that these individuals maintain activity levels consistent
ith the maintenance of fitness up to 2 years (23).
RI. The MRS and MRI were performed with a 1.5-T
canner (Magnetom VISION, Siemens, Erlangen, Ger-
any). For imaging, subjects were studied in the supine
osition with a phased-array body coil. Short- and long-axis
ine MRI were performed with a 2-dimensional gradient
cho sequence and a slice thickness of 8 mm as described
reviously (24). Right ventricular (RV) function as well as
V function and mass were analyzed with the ARGUS
oftware version VB31B (Siemens) (24).
1P-MRS. Patients were examined in the prone position
n a commercially available double resonant 31P/1H-surface
oil as previously described (5,25). An external reference was
laced below the coil for absolute quantification (25).
nitially, 2-dimensional gradient echo short-axis images
ere acquired for anatomical information. After an au-
omatic phase-sensitive map-shim, a 31P-3-dimensional-
hemical shift imaging sequence was started (double-
blique orientation, field of view 400  400  320 mm3,
6  16  8 phase encoding steps). To increase the signal
o noise ratio, nuclear Overhauser enhancement was em-
loyed. Total examination time ranged from 45 to 60 min,
epending on heart rate. A SUN Sparc Station 20 (SUN
icrosystems, Grasbrunn, Germany) was used for post-
rocessing as previously described (25). The short-axis
mages were manually segmented. The Spatial Localization
ith Optimum Pointspread Function (SLOOP)–program
as run to reconstruct local spectra, taking into account the
1-field strength, the flip angle, and standard T1-values; the
esonance amplitudes in the local spectra were fitted with
AMARES” (a method for accurate and reproducible spec-
roscopic fitting) (26). The applied prior knowledge allowed
ndependent fitting for PCr and ATP with an allowed
inewidth in an interval between 2 and 20 Hz and took
-coupling for ATP of 16 Hz into account. Correction for
he effect of saturation was considered with the mean time
f repetition of each experiment, the actual flip angle and
ublished T1-values. Differences in coil loading were taken
nto account by calculation of the presumed B1-field accord-
ng to Biot-Savart laws. Nuclear Overhauser enhancement
ffects were corrected, as previously described (5); briefly,
he values for PCr and gamma ATP were 1.6 and 1.4. A
patially dependent consideration of nuclear Overhauser
nhancement was not used. The amplitude of the resonance ff gamma ATP was taken as the value for ATP. Owing to
he optimal adaptation of voxel shape to anatomical regions,
o blood correction was necessary.
stimation of myocardial efficiency. The LV work power
nd myocardial efficiency in patients with DCM have
reviously been determined with echocardiography and
ET analysis of oxidative metabolism ([11C] acetate)
22,27). To determine myocardial efficiency, the functional
arameter (LV work power/gram  heart rate  blood
ressure  stroke volume/LV mass) was divided by the
etabolic parameter (LV kmono). In contrast to LV kmono,
hich has a dimension beneath 0, the metabolic parameter
nalyzed in the present study (PCr concentration) has a
imension above 0. To allow comparison of the present data
ith previous PET data, the functional parameter “LV work
ower/gram” data was multiplied with the metabolic pa-
ameter (PCr concentration).
tatistics. NCSS statistical software (Kayesville, Utah) was
sed to perform multivariate analysis of variance procedures
etween patients randomized to the exercise and control
roups. Group (exercise or control) and test (baseline vs.
ollow-up) were respected as factors, and the exercise test
ariable (e.g., peak VO2, heart rate) as the response variable.
his was followed by a Bonferroni post hoc procedure for
ithin-group comparisons. Data are presented as mean
SD. Evaluation of MRI and MRS datasets was
erformed blinded.
esults
xercise testing responses. Exercise testing responses be-
ore and after the study period are presented in Table 2.
oth groups achieved mean maximal respiratory exchange
atios 1.1 and mean perceived exertion levels 19.0,
uggesting that maximal efforts were generally achieved. No
ifferences were observed within or between groups in
aximal heart rate or blood pressure. The exercise group
emonstrated a 17% increase in peak VO2 (21.7  3.8
l/kg/min vs. 25.3  5.2 ml/kg/min, p  0.05), a 14%
ncrease in exercise time (p  0.05), and a 22% increase in
eak watts achieved. No differences were observed among
ontrol subjects in these measures of exercise tolerance.
At the lactate threshold, marked improvements in exer-
ise responses were documented in the exercise group. A
6% increase in VO2 (13.2  4.0 ml/kg/min vs. 19.3  5.3
l/kg/min, p  0.01), a 78% increase in exercise time
4.2  2.1 min to 7.5  2.5 min, p  0.01), and an 81%
ncrease in peak watts achieved (58 32 W to 105 44 W,
 0.01) were observed at this point. Concomitant
ncreases in heart rate (p  0.05), minute ventilation (p 
.01), VCO2 (p 0.01), and respiratory exchange ratio (p
.01) were observed.
RI. The LV mass, LV and RV end-diastolic volume,
nd-systolic volume, stroke volume, and EF are presented in
able 3. Overall, changes in measures of LV size andunction were not significantly different between groups at 2
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Myocardial Metabolism and Exercise Training in DCM May 13, 2008:1883–91onths. However, a reduction in end-systolic volume (163 
8 ml to 136 69 ml; p 0.05) and an improvement in EF
30  15% to 37  15%; p  0.005) were observed in the
xercise and Gas Exchange Data
Table 2 Exercise and Gas Exchange Data
Exercise
Pre Post
Rest
Heart rate (beats/min) 73 17 77 12
Systolic BP (mm Hg) 146 21 137 27
Diastolic BP (mm Hg) 90 10 85 13
Lactate threshold
Heart rate (beats/min) 105 20 125 4*
Systolic BP (mm Hg) 169 34 169 37
Diastolic BP (mm Hg) 94 20 92 17
VO2 (ml/min) 964.4 334 1,432 435†
VO2 (ml/kg/min) 12.8 4.0 19.0 5.1†
Minute ventilation 24.5 8.3 40.3 13.5
CO2 production (ml/min) 806.9 335 1,394 505†
Respiratory exchange ratio 0.82 0.01 0.96 0.09
Lactate (mmol/l) 1.11 0.4 1.53 0.56
Exercise time (min) 4.0 2.1 7.7 2.4†
Perceived exertion 10.9 2.8 11.6 2.3
Watts 55.0 32 104.2 42†
Maximal exercise
Heart rate (beats/min) 153 22 155 17
Systolic BP (mm Hg) 197 40 193 37
Diastolic BP (mm Hg) 105 18 96 17
VO2 (ml/min) 1,623.3 368 1,885.3 457
VO2 (ml/kg/min) 21.7 3.8 25.3 5.2*
Minute ventilation 55.7 11.7 71.2 8.1
CO2 production (ml/min) 1,812.9 308 2,230.2 468*
Respiratory exchange ratio 1.11 0.05 1.19 0.09
Lactate (mmol/l) 2.65 1.02 3.59 0.82
Exercise time (min) 9.2 1.9 10.5 2.6*
Perceived exertion 19.5 0.65 19.5 0.5
Watts 134.6 36.4 164.2 48.8
ata expressed as mean  SD. The p value between groups (exercise vs. control) column refers to
ollow-up). †p  0.01 within group (baseline vs. 8-month follow-up).
BP  blood pressure; CO2  carbon dioxide; VO2  oxygen uptake.
RI Measures of Ventricular Function
Table 3 MRI Measures of Ventricular Function
Parameter
Baseline
Control Exercise
Left ventricle
Mass (g) 172 52 167 54 1
EDV (ml) 284 105 222 79 2
ESV (ml) 217 117 163 78 2
SV (ml) 67 20 59 23
EF (%) 31 15 30 15
Right ventricle
EDV (ml) 106 25 113 43 1
ESV (ml) 40 15 45 22
SV (ml) 66 15 68 35
EF (%) 63 9 59 16ll data presented as mean SD. No significant differences between groups, either at baseline or at foll
EDV  end-diastolic volume; EF  ejection fraction; ESV  end-systolic volume; MRI  magnetic resonxercise group after 8 months compared with baseline. In
ontrast, these parameters were unchanged in the control
roup. No significant differences in RV size or function
Control
p Value
Exercise vs. ControlPre Post
78 11 71 23 0.47
144 16 139 14 0.81
93 11 89 12 0.92
119 16 120 19 0.06
162 18 159 19 0.81
99 8 90 13 0.47
949.5 201 1,045.8 337 0.06
12.4 2.6 13.1 3.3 0.02
24.5 6.7 22.4 11.0 0.03
787.2 189 934.2 350 0.04
0.83 0.08 0.88 0.03 0.10
1.08 0.26 1.38 0.48 0.07
4.2 1.2 5.1 1.9 0.02
11.5 2.2 11.4 2.2 0.60
55.8 19 66.7 34 0.05
152 18 157 19 0.83
187 23 180 24 0.82
102 8 95 11 0.79
1,520.4 362 1,653.9 388 0.58
19.5 2.7 20.8 2.7 0.30
57.3 13.2 57.8 16.0 0.10
1,779.3 302 1,930.6 386 0.35
1.18 0.07 1.17 0.10 0.35
2.18 0.87 2.78 1.29 0.63
9.2 2.0 9.6 2.7 0.09
19.7 0.46 9.3 0.47 0.26
130.4 35.4 137.5 36.5 0.35
tween-group main effect from analysis of variance. *p  0.05 within group (baseline vs. 8-month
2-Month Follow-Up 8-Month Follow-Up
ol Exercise Control Exercise
4 146 31 167 54 142 40
22 210 82 272 132 210 88
25 138 68 199 135 136 69*
4 72 39 72 15 72 41
5 36 14 31 14 37 15*
6 122 42 121 25 120 48
8 51 23 50 16 46 23
6 71 35 72 14 74 38
1 57 15 59 8 59 14†
†
the beContr
73 4
67 1
05 1
59 1
28 1
09 2
47 1
63 1
58 1ow-up (p  0.05). *p  0.05 for comparison between baseline and 8-month follow-up.
ance imaging; SV  stroke volume.
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May 13, 2008:1883–91 Myocardial Metabolism and Exercise Training in DCMere observed within or between either group during the
raining period or after the 8-month follow-up.
1P-MRS. Table 4 summarizes absolute and relative con-
entrations of LV high-energy phosphates at baseline and
uring follow-up. Importantly, no significant changes were
bserved in myocardial energetics for either the exercise or
ontrol groups, as depicted in Figure 1, which presents
aired data for individual patients. For the control group,
ost patients showed similar PCr concentrations during
ollow-up, as shown in the example in Figure 2. For the
xercise group, a tendency toward improved PCr concen-
ration (PCr baseline 6.0  1.8, PCr 8-month follow-up
.5  2.5; all units in mmol/kg wet heart weight) could be
bserved, as shown in the example in Figure 3.
stimation of myocardial efficiency. Table 5 summarizes
hanges between baseline and 8-month follow-up in mea-
ures of LV work power and efficiency. A trend for higher
orward work efficiency was observed for the trained group;
owever, this change was not statistically significant.
iscussion
he major findings from the present study were: 1) 8
onths of ET improved exercise capacity and LV systolic
unction in patients with DCM; and 2) these improvements
ere neutral with regard to effects on cardiac energy metab-
lism, because no adverse short-term (2-month) or long-term
8-month) effects on myocardial energetics were observed.
hese findings provide further support for the benefits of ET
n patients with impaired LV function due to DCM.
T in chronic heart failure. Studies performed in recent
ears have provided strong evidence for the benefits of ET
n chronic heart failure. Although these benefits are largely
hought to occur in the periphery (e.g., skeletal muscle and
asculature adaptations), favorable myocardial adaptations
ave also been reported (28). The latter studies have
ncluded reduced adrenergic and increased vagal tone and
mprovements in myocardial perfusion (20,29) and myocar-
ial oxidative metabolism (22). Nevertheless, ET remains
nderused, in part because data on survival are limited (20).
recent collaborative meta-analysis of 801 patients ran-
omized to ET demonstrated a reduction in mortality in
atients with heart failure due to LV systolic dysfunction
19). However, the mechanisms for the potential benefits of
raining on survival are not fully understood.
Cr and ATP Concentrations and Their Ratios Measured by 31P-MR
Table 4 PCr and ATP Concentrations and Their Ratios Measure
Parameter
Baseline
Control Exercise Co
PCr 6.2 1.5 6.0 1.8 6.1
ATP 4.1 0.8 4.6 1.2 4.0
PCr/ATP 1.54 0.34 1.38 0.42 1.49
ata presented as mean  SD; concentrations in mmol/kg wet heart tissue weight. No significa
hanges during follow-up (p  0.05).
ATP  adenosine triphosphate; PCr  phosphocreatine; 31P-MRS  phosphorus-31 magnetic resonanraining responses. We observed a 17% increase in peak
O2 and a considerable 46% increase in VO2 at the lactate
hreshold in patients randomized to the exercise group.
hese training effects are consistent with previous reports
30). A unique feature of the current study was the
valuation of myocardial adaptations to both short- and
ong-term training. Initially, a 2-month supervised train-
ng regimen was used, followed by an additional 6-month
eriod with self-regulation. Although we do not have
xercise test responses at the 8-month evaluation, we
Figure 1 Change in PCr Concentrations During Follow-Up
(A) Control and (B) exercise group. The blue lines represent single patients.
The green dotted line represents the mean of the respective patient group.
Black bars located on the left as well as the right side of the single values
show the SD at baseline (left) and at 8-month follow-up (right). PCr  phos-
phocreatine; 0  baseline examination; 8  8-month follow-up.
31P-MRS
-Month Follow-Up 8-Month Follow-Up
Exercise Control Exercise
6.1 2.0 6.3 1.9 6.5 2.5
4.3 0.7 4.2 0.8 4.6 0.9
8 1.40 0.38 1.54 0.38 1.42 0.42
rences between groups, either at baseline or at follow-up. Additionally, there were no significantS
d by
2
ntrol
 2.2
 0.6
 0.3
nt diffece spectroscopy.
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Myocardial Metabolism and Exercise Training in DCM May 13, 2008:1883–91ecently observed that self-regulation leads to improve-
ents in exercise capacity that are similar to those among
onitored patients (31) and that patients maintained
hysical activity patterns and fitness levels at least 2 years
Figure 2 Phosphorus-31 Spectra and Magnetic Resonance Ima
Almost completely unchanged morphologic (mass), functional (ejection fraction [EF
tions) parameters during follow-up. The black line with a fixed starting point at the
concentration during follow-up. LV  left ventricular.
Figure 3 Phosphorus-31 Spectra and Magnetic Resonance Ima
Improvement of morphologic (mass), functional (EF), and metabolic (PCr and ATP c
at the peak of the PCr signal of the baseline examination demonstrates the tendefter participation in a 2-month rehabilitation program
23). Thus, the myocardial adaptations observed at 8
onths are likely attributable at least in part to sustained
ctivity levels (23,31).
f a 64-Year-Old Male Patient of the Control Group
metabolic (phosphocreatine [PCr] and adenosine triphosphate [ATP] concentra-
of the PCr signal of the baseline examination demonstrates the unchanged PCr
f a 35-Year-Old Male Patient of the Exercise Group
trations) parameters during follow-up. The black line with a fixed starting point
ward increasing PCr concentrations during follow-up. Abbreviations as in Figure 2.ges o
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May 13, 2008:1883–91 Myocardial Metabolism and Exercise Training in DCMardiac function. Although the effects of training on the
yocardium have been widely studied in patients with
schemic cardiomyopathy, little is known regarding the
ffects of training in patients with DCM. With MRI, we
ecently found no significant changes in ventricular volumes
r function after short-term ET in patients with DCM (16).
his concurs with the present findings, in which no signif-
cant changes in LV volumes or function were observed after
months of training. Long-term ET (6 to 12 months) has
een shown to have favorable effects on both quality of life
nd clinical outcomes (20) and to improve LV functional
arameters in patients with heart failure (30,32). The
resent findings support the concept that these favorable
daptations in LV function might occur with longer-term
hysical activity. Changes in myocardial perfusion might
lay an important role in these adaptations (33); however,
he molecular mechanisms underlying this effect remain to
e investigated.
Little is known about the effects of training on the RV,
lthough it has been shown that RV afterload might be an
mportant determinant of exercise capacity (34) and RVEF is
n important predictor of survival in patients with advanced
eart failure (35). Moreover, data concerning effects of ET on
he RV, although limited to short-term training and the EF,
ave reported no significant changes (35). Including long-term
raining and a detailed analysis of RV morphology and func-
ion, the present study similarly did not demonstrate any
hanges in RV volumes or function.
ardiac energy metabolism. Reductions of high-energy
hosphate content, which can be studied noninvasively with
1P-MRS, are a key feature of DCM (6). The degree of
etabolic alterations assessed by the ratio of the high-
nergy molecules PCr to ATP has prognostic value for both
verall and cardiovascular mortality (7). However, end-stage
eart failure might lead to the combined reduction of PCr
nd ATP (36), warranting separate quantitative analyses of
Cr and ATP content (37). For the present study the
uantitative MRS SLOOP technique was applied, which
as the advantage of precise anatomic localization combined
ith increased sensitivity and reliability (25). Anatomic
oxel alignment by SLOOP yields both PCr and ATP
ontent with minimal contamination (5). In the present
tudy, the high-energy metabolite levels as well as their ratio
t well with previously published data in comparably dis-
ased patients with DCM and cardiac manifestations of
yocardial Work and Efficiency at 8 Months
Table 5 Myocardial Work and Efficiency at 8 Months
Training Group
Baseline Follow-Up
LV work power (mm Hg · l/min) 660 288 766 453
LV work power/g (mm Hg · l/g · min) 4.3 1.7 5.2 2.3
Forward work efficiency (mm Hg · l/g) 27.0 13.8 35.9 24.5
ll values not significant (p  0.05).
LV  left ventricular.uscular dystrophy (6,38) (mean EF in the present study q1%; most were in Weber class A and B, and none were
eber class D).
ffects of ET on energy use in cardiac muscle. Whether
he additional load caused by ET on the failing heart would
ead to deterioration of cardiac energy metabolism has not
een fully explored. It is known for example that positive
notropic therapy increases mortality in heart failure (12,13)
nd acute increases in cardiac work decrease phosphocre-
tine levels in both human and animal studies (39,40). The
resent study shows that the effect of chronic ET (i.e.,
ncreased energy demand and use in 5 45-min periods in our
etting) is not detrimental on cardiac energetics and was
ven beneficial in individual patients This is in accordance
ith recent PET findings of Stolen et al. (22), who
emonstrated an improvement in oxidative metabolism
ollowing ET. Thus, DCM patients are able to withstand
he additional cardiac work necessitated by ET without
epleting their cardiac high-energy phosphate levels. This
bservation, together with the beneficial effects on cardiac
unction, suggests that ET has the potential to improve
rognosis in DCM, although this question needs to be
tudied in a large prospective randomized trial.
tudy limitations. Contrast-enhanced MRI studies were
ot performed. Thus, an analysis of first pass perfusion
efects for correlation to previous PET perfusion results
21,22) as well as analysis of late enhancement for detection
f myocardial fibrosis was not possible (41). The sample size
f the study is small; however, previous studies showed that
sample size such as 24 patients is an adequate number to
ocument a training effect (23,31). Nevertheless, sample
ize might explain why no significant changes in RV
unction were observed, because detection of changes in RV
unction require larger sample sizes than the LV (42) and,
dditionally, small sample size might also be the reason for
he nonsignificant change in LV work power and efficiency.
The ET was not supervised in the interval between early
2-month) and late follow-up (8-month). Therefore, the
nergy expenditure during this period is not documented
recisely. Nevertheless, the exercise group was encouraged
o remain physically active, and the surrogate measure for
his (peak VO2) suggests that they maintained their fitness.
oreover, previous reports have shown a comparable effect
f ET with self-regulation and supervised training at our
acility (23,31).
This mechanistic proof-of-principle study was not ade-
Control Group
Change (%) Baseline Follow-Up Change (%)
16.1 777 280 733 92 5.7
20.9 4.8 2.1 5.0 1.9 4.2
32.9 30.6 15.4 32.1 16.3 4.9uately powered to address whether ET has an effect on
m
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y a much larger clinical trial. Finally, the applied technique
f 31P-MRS only allowed the analysis of PCr and ATP
ontent. No changes were found concerning this aspect of
nergy metabolism. However, the rise of peak VO2 indicates
ncreased ATP synthesis and use and therefore altered flux
hrough the purine pool (43).
onclusions
xercise training among patients with DCM results in
ignificant improvements in exercise capacity, which are
imilar to those observed in recent studies among patients
ith ischemic cardiomyopathy. Training had no short- or
ong-term adverse effects on myocardial size, function, or
nergetics. Rather, training resulted in a modest but signif-
cant improvement in LV systolic function. These findings
rovide further support for ET as a treatment modality in
atients with impaired LV function due to DCM.
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